Results of the Oxurion General Meeting

On May 22, 2025, Oxurion NV, a biopharmaceutical company based in Leuven, Belgium, announced the results of its general shareholders' meeting held on May 13, 2025. All items on the agenda were approved by the shareholders present. Documents relating to this meeting are available on Oxurion's website.

The press release emphasizes the importance of not taking forward-looking statements as certainties. Oxurion highlights the risks and uncertainties inherent in these statements and disclaims any obligation to update them. It specifies that this press release does not constitute an offer to sell assets or securities, including in the United States, without prior registration.